FacultyFaculty/Author Profile
Amy W. Schulman

Amy W. Schulman

Pfizer Inc.
Executive Vice President & General Counsel, President and General Manager, Nutrition
New York, NY, USA

Amy W. Schulman is recognized as an innovative, results-focused leader in the legal and health care professions and a champion for diversity and women's professional advancement. As General Counsel, she heads a division of professionals who handle some of the most complex, challenging legal matters within a highly regulated industry. Ms. Schulman is also the Business Unit Lead for Pfizer Consumer Healthcare (PCH) - a $4 billion business, with a global footprint of operations in more than 90 countries. PCH develops, manufactures and markets leading non-prescription medicines, vitamins and nutritional products including two of the top 10 global brands - Advil (the world's #1 analgesic brand)  and Centrum (the world's #1 multivitamin).

In 2010, in addition to her role as the General Counsel, Ms. Schulman was asked to lead Pfizer Nutrition-a $2.1 billion, global business and leading provider of infant formulas and other nutritional products for children in more than 60 countries. She successfully led the business to increased profitably and above market performance and was instrumental in the agreement to sell the business to Nestlé for $11.85 billion, a sale currently under regulatory review.
At Pfizer, Ms. Schulman devised a groundbreaking approach to engaging outside counsel that transforms the traditional billable-hour model and produces better results for the company and its firms. In a December 2009 cover story, The American Lawyer wrote: "Amy Schulman knows how the game is played and has set out to change all the rules." Ms. Schulman and the Pfizer Legal Alliance also have been featured in numerous other publications, including The Wall Street Journal, The Financial Times, The New York Times and The American Lawyer.
Ms. Schulman joined Pfizer as General Counsel in June 2008, when the company was exploring the purchase of Wyeth Pharmaceuticals. She played a key role in the negotiations leading up to what became the largest pharmaceutical acquisition in history.

A Phi Beta Kappa graduate of Wesleyan University, Ms. Schulman earned her J.D. from Yale Law School in 1989. She serves on the Board of Directors for Wesleyan University and the Brooklyn Academy of Music.


  • twitter
  • LinkedIn
  • YouTube
  • RSS

All Contents Copyright © 1996-2018 Practising Law Institute. Continuing Legal Education since 1933.

© 2018 PLI PRACTISING LAW INSTITUTE. All rights reserved. The PLI logo is a service mark of PLI.